147 related articles for article (PubMed ID: 16456990)
1. Medical journal criticizes Merck over Vioxx data.
Berenson A
N Y Times Web; 2005 Dec; ():A1, C13. PubMed ID: 16456990
[No Abstract] [Full Text] [Related]
2. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag".
Armstrong D
Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016
[No Abstract] [Full Text] [Related]
3. Manipulating a journal article.
N Y Times Web; 2005 Dec; ():WK11. PubMed ID: 16453395
[No Abstract] [Full Text] [Related]
4. NEJM editor gives pretrial evidence in Vioxx case.
Tanne JH
BMJ; 2006 Feb; 332(7536):255. PubMed ID: 16455704
[No Abstract] [Full Text] [Related]
5. Vioxx doctors wooed by Merck are now its foes.
Tesoriero HW
Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
[No Abstract] [Full Text] [Related]
6. Evidence in Vioxx suits shows intervention by Merck officials.
Berenson A
N Y Times Web; 2005 Apr; ():A1, A32. PubMed ID: 15940861
[No Abstract] [Full Text] [Related]
7. Journal grows suspicious of Vioxx data.
Wadman M
Nature; 2005 Dec; 438(7070):899. PubMed ID: 16355178
[No Abstract] [Full Text] [Related]
8. Lapses at the new England journal of medicine.
Smith R
J R Soc Med; 2006 Aug; 99(8):380-2. PubMed ID: 16893926
[No Abstract] [Full Text] [Related]
9. The lessons of Vioxx--drug safety and sales.
Waxman HA
N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862
[No Abstract] [Full Text] [Related]
10. Open conflict on the handling of the Merck drug Vioxx by editorial giants.
Edwards RG
Reprod Biomed Online; 2006 Dec; 13(6):905. PubMed ID: 17169217
[No Abstract] [Full Text] [Related]
11. Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx.
Moynihan R
BMJ; 2009 Apr; 338():b1432. PubMed ID: 19349350
[No Abstract] [Full Text] [Related]
12. Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
Couzin J
Science; 2005 Dec; 310(5755):1755. PubMed ID: 16357236
[No Abstract] [Full Text] [Related]
13. Will Merck survive Vioxx?
Simons J; Stipp D
Fortune; 2004 Nov; 150(9):90-2, 94, 96-7 passim. PubMed ID: 15543824
[No Abstract] [Full Text] [Related]
14. Merck VIOXX "warning" is questioned.
Allen TS; Henderson JH
Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
[No Abstract] [Full Text] [Related]
15. Merck disguised "marketing publication" as medical journal to help promote Vioxx, court hears.
Moynihan R
BMJ; 2009 Apr; 338():b1714. PubMed ID: 19401326
[No Abstract] [Full Text] [Related]
16. Merck defends Vioxx in court, as publisher apologises for fake journal.
Moynihan R
BMJ; 2009 May; 338():b1914. PubMed ID: 19433504
[No Abstract] [Full Text] [Related]
17. What have we learnt from Vioxx?
Krumholz HM; Ross JS; Presler AH; Egilman DS
BMJ; 2007 Jan; 334(7585):120-3. PubMed ID: 17235089
[TBL] [Abstract][Full Text] [Related]
18. Physician, divest thyself.
Levin PJ; McGee G
Am J Bioeth; 2006; 6(2):1-2. PubMed ID: 16500836
[No Abstract] [Full Text] [Related]
19. Merck's actions surrounding Vioxx.
Heinley M
PLoS Med; 2006 Jun; 3(6):e286; author reply e285. PubMed ID: 16789808
[No Abstract] [Full Text] [Related]
20. The story of Vioxx--no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.
Cahana A; Mauron A
J Anesth; 2006; 20(4):348-51. PubMed ID: 17072707
[No Abstract] [Full Text] [Related]
[Next] [New Search]